A human cellular model for colorectal anastomotic repair: The effect of localization and transforming growth factor-β1 treatment on collagen deposition and biomarkers

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

A human cellular model for colorectal anastomotic repair : The effect of localization and transforming growth factor-β1 treatment on collagen deposition and biomarkers. / Türlü, Ceylan; Willumsen, Nicholas; Marando, Debora; Schjerling, Peter; Biskup, Edyta; Hannibal, Jens; Jorgensen, Lars N.; Ågren, Magnus S.

In: International Journal of Molecular Sciences, Vol. 22, No. 4, 1616, 2021, p. 1-17.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Türlü, C, Willumsen, N, Marando, D, Schjerling, P, Biskup, E, Hannibal, J, Jorgensen, LN & Ågren, MS 2021, 'A human cellular model for colorectal anastomotic repair: The effect of localization and transforming growth factor-β1 treatment on collagen deposition and biomarkers', International Journal of Molecular Sciences, vol. 22, no. 4, 1616, pp. 1-17. https://doi.org/10.3390/ijms22041616

APA

Türlü, C., Willumsen, N., Marando, D., Schjerling, P., Biskup, E., Hannibal, J., Jorgensen, L. N., & Ågren, M. S. (2021). A human cellular model for colorectal anastomotic repair: The effect of localization and transforming growth factor-β1 treatment on collagen deposition and biomarkers. International Journal of Molecular Sciences, 22(4), 1-17. [1616]. https://doi.org/10.3390/ijms22041616

Vancouver

Türlü C, Willumsen N, Marando D, Schjerling P, Biskup E, Hannibal J et al. A human cellular model for colorectal anastomotic repair: The effect of localization and transforming growth factor-β1 treatment on collagen deposition and biomarkers. International Journal of Molecular Sciences. 2021;22(4):1-17. 1616. https://doi.org/10.3390/ijms22041616

Author

Türlü, Ceylan ; Willumsen, Nicholas ; Marando, Debora ; Schjerling, Peter ; Biskup, Edyta ; Hannibal, Jens ; Jorgensen, Lars N. ; Ågren, Magnus S. / A human cellular model for colorectal anastomotic repair : The effect of localization and transforming growth factor-β1 treatment on collagen deposition and biomarkers. In: International Journal of Molecular Sciences. 2021 ; Vol. 22, No. 4. pp. 1-17.

Bibtex

@article{13135276122e4791a7e96d9b5899e3b3,
title = "A human cellular model for colorectal anastomotic repair: The effect of localization and transforming growth factor-β1 treatment on collagen deposition and biomarkers",
abstract = "Anastomotic leakage (AL) is a devastating complication after colorectal surgery, possibly due to the loss of stabilizing collagen fibers in the submucosa. Our aim was to assess the formation of collagen in the colon versus the rectum with or without transforming growth factor (TGF)-β1 exposure in a human cellular model of colorectal repair. Primary fibroblasts were isolated by an explant procedure from clinically resected tissue rings during anastomosis construction in 19 consecutive colorectal patients who underwent laparoscopy. The cells, identified as fibroblasts by morphologic characteristics and flow cytometry analysis (CD90+), were cultured for 8 days and in 12 patients in the presence of 1 ng/mL TGF-β1. Total collagen deposition was measured colorimetrically after Sirius red staining of fixed cell layers, and type I, III, and VI collagen biosynthesis and degradation were specifically determined by the biomarkers PINP, PRO-C3, PRO-C6, and C3M in conditioned media by competitive enzyme-linked immunosorbent assays. Total collagen deposition by fibroblasts from the colon and rectum did not significantly differ. TGF-β1 treatment increased PINP, PRO-C6, and total collagen deposition. Mechanistically, TGF-β1 treatment increased COL1A1 and ACTA2 (encoding α-smooth muscle actin), and decreased COL6A1 and MMP2 mRNA levels in colorectal fibroblasts. In conclusion, we found no effect of anatomic localization on collagen production by fibroblasts derived from the large intestine. TGF-β1 represents a potential therapeutic agent for the prevention of AL by increasing type I collagen synthesis and collagen deposition.",
keywords = "Anasto-motic leakage, Collagen, Colon, Extracellular matrix, Growth factors, Rectum, Wound healing",
author = "Ceylan T{\"u}rl{\"u} and Nicholas Willumsen and Debora Marando and Peter Schjerling and Edyta Biskup and Jens Hannibal and Jorgensen, {Lars N.} and {\AA}gren, {Magnus S.}",
year = "2021",
doi = "10.3390/ijms22041616",
language = "English",
volume = "22",
pages = "1--17",
journal = "International Journal of Molecular Sciences (CD-ROM)",
issn = "1424-6783",
publisher = "M D P I AG",
number = "4",

}

RIS

TY - JOUR

T1 - A human cellular model for colorectal anastomotic repair

T2 - The effect of localization and transforming growth factor-β1 treatment on collagen deposition and biomarkers

AU - Türlü, Ceylan

AU - Willumsen, Nicholas

AU - Marando, Debora

AU - Schjerling, Peter

AU - Biskup, Edyta

AU - Hannibal, Jens

AU - Jorgensen, Lars N.

AU - Ågren, Magnus S.

PY - 2021

Y1 - 2021

N2 - Anastomotic leakage (AL) is a devastating complication after colorectal surgery, possibly due to the loss of stabilizing collagen fibers in the submucosa. Our aim was to assess the formation of collagen in the colon versus the rectum with or without transforming growth factor (TGF)-β1 exposure in a human cellular model of colorectal repair. Primary fibroblasts were isolated by an explant procedure from clinically resected tissue rings during anastomosis construction in 19 consecutive colorectal patients who underwent laparoscopy. The cells, identified as fibroblasts by morphologic characteristics and flow cytometry analysis (CD90+), were cultured for 8 days and in 12 patients in the presence of 1 ng/mL TGF-β1. Total collagen deposition was measured colorimetrically after Sirius red staining of fixed cell layers, and type I, III, and VI collagen biosynthesis and degradation were specifically determined by the biomarkers PINP, PRO-C3, PRO-C6, and C3M in conditioned media by competitive enzyme-linked immunosorbent assays. Total collagen deposition by fibroblasts from the colon and rectum did not significantly differ. TGF-β1 treatment increased PINP, PRO-C6, and total collagen deposition. Mechanistically, TGF-β1 treatment increased COL1A1 and ACTA2 (encoding α-smooth muscle actin), and decreased COL6A1 and MMP2 mRNA levels in colorectal fibroblasts. In conclusion, we found no effect of anatomic localization on collagen production by fibroblasts derived from the large intestine. TGF-β1 represents a potential therapeutic agent for the prevention of AL by increasing type I collagen synthesis and collagen deposition.

AB - Anastomotic leakage (AL) is a devastating complication after colorectal surgery, possibly due to the loss of stabilizing collagen fibers in the submucosa. Our aim was to assess the formation of collagen in the colon versus the rectum with or without transforming growth factor (TGF)-β1 exposure in a human cellular model of colorectal repair. Primary fibroblasts were isolated by an explant procedure from clinically resected tissue rings during anastomosis construction in 19 consecutive colorectal patients who underwent laparoscopy. The cells, identified as fibroblasts by morphologic characteristics and flow cytometry analysis (CD90+), were cultured for 8 days and in 12 patients in the presence of 1 ng/mL TGF-β1. Total collagen deposition was measured colorimetrically after Sirius red staining of fixed cell layers, and type I, III, and VI collagen biosynthesis and degradation were specifically determined by the biomarkers PINP, PRO-C3, PRO-C6, and C3M in conditioned media by competitive enzyme-linked immunosorbent assays. Total collagen deposition by fibroblasts from the colon and rectum did not significantly differ. TGF-β1 treatment increased PINP, PRO-C6, and total collagen deposition. Mechanistically, TGF-β1 treatment increased COL1A1 and ACTA2 (encoding α-smooth muscle actin), and decreased COL6A1 and MMP2 mRNA levels in colorectal fibroblasts. In conclusion, we found no effect of anatomic localization on collagen production by fibroblasts derived from the large intestine. TGF-β1 represents a potential therapeutic agent for the prevention of AL by increasing type I collagen synthesis and collagen deposition.

KW - Anasto-motic leakage

KW - Collagen

KW - Colon

KW - Extracellular matrix

KW - Growth factors

KW - Rectum

KW - Wound healing

U2 - 10.3390/ijms22041616

DO - 10.3390/ijms22041616

M3 - Journal article

C2 - 33562728

AN - SCOPUS:85100495993

VL - 22

SP - 1

EP - 17

JO - International Journal of Molecular Sciences (CD-ROM)

JF - International Journal of Molecular Sciences (CD-ROM)

SN - 1424-6783

IS - 4

M1 - 1616

ER -

ID: 256938959